The Children's Memorial Health Institute Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01506557
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

The Children's Memorial Health Institute

Active Ingredients

Drugs in Phase 4 Trials (1)

vitamin d3 (2 trials)

Drugs in Phase 3 Trials (2)

sirolimus (rapamune) (1 trial)

vigabatrin (sabril) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3